Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Capital Expenditures came in at -$67.0 million in Q2 2026, down 2.75% year-over-year from -$68.9 million in Q2 2025, and up 13.61% quarter-over-quarter from -$77.6 million in Q1 2026.
Analysis
Stevanato Group S.p.A (STVN) Capital Expenditures (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Capital Expenditures for 7 consecutive years, with -$67.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Capital Expenditures fell 2.75% year-over-year to -$67.0 million in Q2 2026; TTM through Jun 2026 was -$302.8 million, a 6.96% decrease from a year earlier, with the FY2025 full-year figure at -$307.0 million, up 5.05% from the prior year.
- Capital Expenditures was -$67.0 million for Q2 2026 at Stevanato Group S.p.A, up from -$77.6 million in the prior quarter.
- Over five years, Capital Expenditures peaked at -$40.7 million in Q3 2022 and troughed at -$142.9 million in Q3 2023.
- A 5-year average of -$82.6 million and a median of -$75.8 million in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures plunged 250.89% in 2023 and jumped 65.84% in 2024, its largest moves.
- Over 5 years, Capital Expenditures stood at -$69.3 million in 2022, then decreased by 27.36% to -$88.2 million in 2023, then declined by 7.67% to -$95.0 million in 2024, then slipped by 9.42% to -$103.9 million in 2025, then surged by 35.54% to -$67.0 million in 2026.
- The last three Capital Expenditures figures came in at -$67.0 million (Q2 2026), -$77.6 million (Q1 2026), and -$103.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 143.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 111.00 Mn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 43.20 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 116.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -67.01 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 1.07 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 617,000.00 |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 29,823.00 |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -67.01 Mn |
| Mar 31, 2026 | -77.57 Mn |
| Dec 31, 2025 | -103.95 Mn |
| Sep 30, 2025 | -54.26 Mn |
| Jun 30, 2025 | -65.21 Mn |
| Mar 31, 2025 | -74.04 Mn |
| Dec 31, 2024 | -95.00 Mn |
| Sep 30, 2024 | -48.83 Mn |
| Jun 30, 2024 | -74.00 Mn |
| Mar 31, 2024 | -109.22 Mn |
| Dec 31, 2023 | -88.23 Mn |
| Sep 30, 2023 | -142.93 Mn |
| Jun 30, 2023 | -100.40 Mn |
| Mar 31, 2023 | -137.10 Mn |
| Dec 31, 2022 | -69.27 Mn |
| Sep 30, 2022 | -40.73 Mn |
| Jun 30, 2022 | -78.96 Mn |
| Mar 31, 2022 | -59.19 Mn |
| Dec 31, 2021 | -41.53 Mn |
| Sep 30, 2021 | -32.20 Mn |